Lactose (India) Limited (BOM:524202)
India
· Delayed Price · Currency is INR 119.26
+0.58 (0.49%)
At close: Apr 28, 2026
Lactose (India) Revenue
Lactose (India) had revenue of 367.67M INR in the quarter ending December 31, 2025, with 28.03% growth. This brings the company's revenue in the last twelve months to 1.45B, up 23.10% year-over-year. In the fiscal year ending March 31, 2025, Lactose (India) had annual revenue of 1.16B with 2.20% growth.
Revenue (ttm)
1.45B
Revenue Growth
+23.10%
P/S Ratio
1.03
Revenue / Employee
10.38M
Employees
140
Market Cap
1.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.16B | 25.10M | 2.20% |
| Mar 31, 2024 | 1.14B | 480.94M | 73.09% |
| Mar 31, 2023 | 657.96M | 198.57M | 43.23% |
| Mar 31, 2022 | 459.39M | 109.76M | 31.39% |
| Mar 31, 2021 | 349.63M | -50.85M | -12.70% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Coral Laboratories | 875.55M |
| Bilcare | 7.40B |
| Astonea Labs | 1.17B |
| Parnax Lab | 2.28B |
| Bal Pharma | 3.09B |
| Aayush Wellness | 1.29B |
| Accretion Pharmaceuticals | 826.43M |
| Sanjivani Paranteral | 736.34M |